Phesgo full prescribing information
WebEBC & MBC Loading dose: 1,200 mg/600 mg trastuzumab given for approx 8 min. Maintenance dose: 600 mg/600 mg trastuzumab given for approx 5 min. Patients receiving taxane Administer treatment prior to taxane. Recommended initial dose of docetaxel is 75 mg/m 2. EBC Neoadjuvant setting: 3-6 cycles depending on regimen chosen in … WebTalk to a healthcare professional for more information about the benefits and risks of PHESGO. Please see full Prescribing Information for additional Important Safety Information, including most serious side effects. If you cannot afford your medication, visit phesgo.com/financial-support for financial assistance information.
Phesgo full prescribing information
Did you know?
WebSee full prescribing information for details regarding concomitant use of simvastatin with other drugs or grapefruit juice that increase the risk of myopathy and rhabdomyolysis. (2.5, 7.1) • Coumarin Anticoagulants: Obtain INR before simvastatin initiation and monitor INR during simvastatin dosage initiation or adjustment. • WebSee 17 for PATIENT COUNSELING INFORMATION and Medication Guide . Revised: 6/2024 . FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION . 2.1 Assessments Prior to First Dose of UPLIZNA . 2.2 Assessment and Premedication Before Every Infusion . 2.3 Recommended Dosage and Administration
WebPHESGO Prescribing Information. Genentech, Inc. 2024. Important Safety Information & Indications the neoadjuvant treatment of adult patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node-positive) as part of a complete treatment regimen for early breast cancer (EBC) WebSee full prescribing information for complete boxed warning. Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors (5.1).
WebPATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing information are not listed. FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . Lipiodol is an oil-based radio-opaque contrast agent indicated for: • hysterosalpingography in adults • lymphography in adult and pediatric patients WebPlease see the PERJETA IV + trastuzumab IV full Prescribing Information for additional dosing information. Please see PHESGO full Prescribing Information for complete dosing and administration information. 2 Please see additional Important Safety Information on pages 4-6. PHESGO is a ~5 or ~8 minute subcutaneous injection
WebPHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive).
WebJan 1, 2024 · for PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) Breast Cancer The Centers for Medicare & Medicaid Services (CMS) has assigned a permanent J-code for PHESGO effective January 1, 2024. TYPE CODE DESCRIPTION Diagnosis: ICD-10-CM C50.011–C50.019 C50.111–C50.119 C50.211–C50.219 C50.311–C50.319 … problem with epson workforce scanner prefixproblem with epson scanner add documentsWebPATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing information are not listed. FULL PRESCRIBING INFORMATION . 1 … register company in latviaWebIf PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555 Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. problem with equityWebPhesgo® contains pertuzumab, trastuzumab, and hyaluronidase-zzxf. It is best to read this information with our general information about breast cancer. These treatments belong to a group of targeted therapy drugs known as monoclonal antibodies. They both work by targeting specific proteins (receptors). problem with equilibriumWebPHESGO is indicated for use in combination with docetaxel for the treatment of adult patients with HER2-positive metastatic breast cancer who have not received prior anti … problem with equipmentWebNov 16, 2024 · Neoadjuvant Treatment of Breast Cancer. Administer PHESGO every 3 weeks for 3 to 6 cycles as part of a treatment regimen for early breast cancer [see Clinical Studies (14.2)].. Refer to the prescribing information for pertuzumab, administered in combination with trastuzumab and chemotherapy, for recommended dose and dosage modifications. register company in belgium